nach oben

Erschienen in:

01.06.2018 | Clinical study

Safety of adalimumab in patients with Crohn's disease

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

The safety of adalimumab in patients with Crohn's disease is similar to the known safety profile, according to the results of an AbbVie-funded study reported in the American Journal of Gastroenterology, and "adalimumab use was not associated with a doubling of the risk of lymphoma". …

NCT00524537

D'Haens G, et al. Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry. American Journal of Gastroenterology : 5 Jun 2018. Available from: URL: http://doi.org/10.1038/s41395-018-0098-4

Titel: Safety of adalimumab in patients with Crohn's disease
Publikationsdatum: 01.06.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-48106-3

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Safety of adalimumab in patients with Crohn's disease

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Secukinumab

Antibiotics

Oxaliplatin

Prednisone

Acenocoumarol

Adalimumab